Clinical Trial Update: Safety and Efficacy of THR-1442 Compared to Dapagliflozin as Add-on Therapy to Metformin in T2DM [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of THR-1442 as add-on to metformin versus dapagliflozin in type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• THR-1442 (THR-1442)
• metformin (metformin)

Snippet

Sponsor: Newsoara Biopharma Co., Ltd. | Conditions: T2DM | Phase 3 | Status: UNKNOWN